A critical breakthrough in cancer study is emerging with the use of mini-antibodies to restore damaged p53. This vital malignant inhibitor protein is frequently lost in various types of cancer, resulting uncontrolled https://travialist.com/story12403759/nanobodies-reactivate-tumor-suppressor-p53-new-promising-approach-for-malignant-therapy